iCAD, Inc. Announces Sale of Xoft, Its Brachytherapy Business Line, to Elekta

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions announces that Elekta (EKTA-B.ST), the world leader in brachytherapy solutions, has agreed to acquire Xoft, a subsidiary of iCAD, Inc. for approximately $5.5 million and assumed liabilities. Elekta is taking over the business effective immediately and will make final payment no later than November 6, 2023. By acquiring the Xoft® Axxent® Electronic Brachytherapy (eBx®) System®, Elekta will be able to offer electronic brachytherapy technology to provide expanded access to treatment for a range of cancers.

Read the full article: iCAD, Inc. Announces Sale of Xoft, Its Brachytherapy Business Line, to Elekta //

Source: https://www.globenewswire.com/news-release/2023/10/23/2764691/0/en/iCAD-Inc-Announces-Sale-of-Xoft-its-Brachytherapy-Business-Line-to-Elekta.html

Leave a Comment

Your email address will not be published.

Scroll to Top